Irinotecan should not be used in patients who have a severe hypersensitivity to the drug. It is also contraindicated in patients with severe bone marrow suppression. Precautions are necessary for patients with liver impairment, as the drug is metabolized in the liver. Regular blood tests are essential to monitor liver function and blood cell counts during treatment.
